Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial

IntroductionChemotherapy-induced peripheral neuropathy (CIPN) can greatly impair function, leading to disability or truncated treatment in cancer patients. Previous animal studies show that cannabidiol (CBD) and delta-9- tetrahydrocannabinol (THC) can ameliorate CIPN. This study assessed the effect...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Marisa Weiss, Muath Giaddui, Stephanie Kjelstrom, Joseph Gary, Sara Jane Ward, Jessica Burrell, Katherine Diguilio, Gabrielle Bidas, Ebuwa Erebor, Sam Meske, Lisa Saeed, Sarah Windawi, Katherine Aliano Ruiz, Arezoo Ghaneie, Julianne Hibbs, John Marks, David Holtz, Zonera Ali, Aarthi Shevade, Jennifer Sabol, Robin Ciocca, Eric Zeger, Paul Gilman, Sharon Larson, Shoichi Shimamoto, Diana Martinez
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2025-10-01
Rangatū:	Frontiers in Oncology
Ngā marau:	chemotherapy-induced peripheral neuropathy cannabinoids cannabidiol (CBD) delta-9-tetrahydrocannabinol (THC) sensory impairment cancer
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1590168/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!